David Lorente

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

Elena Castro, Nuria Romero-Laorden, Ángela del Pozo et al. · Journal of Clinical Oncology · 2019 · 366 citations · Full text

Tumor clone dynamics in lethal prostate cancer

Suzanne Carreira, Alessandro Romanel, Jane Goodall et al. · Science Translational Medicine · 2014 · 339 citations

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

Bert H. O’Neil, John M. Wallmark, David Lorente et al. · PLoS ONE · 2017 · 299 citations · Full text

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes et al. · European Urology · 2014 · 251 citations · Full text

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

Diletta Bianchini, David Lorente, Alejo Rodríguez‐Vida et al. · European Journal of Cancer · 2013 · 209 citations

Medicinal Chemistry, Urology, Medicine +8